N-(2H-indazol-3-ylmethyl)-5-[[4-(2-oxopyrrolidin-1-yl)phenyl]methyl]pyridine-3-carboxamide
C25H23N5O2 — CID 118213031
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(2H-indazol-3-ylmethyl)-5-[[4-(2-oxopyrrolidin-1-yl)phenyl]methyl]pyridine-3-carboxamide
N-(2H-indazol-3-ylmethyl)-5-[[4-(2-oxopyrrolidin-1-yl)phenyl]methyl]pyridine-3-carboxamide (PubChem CID 118213031) has the molecular formula C25H23N5O2 and a molecular weight of 425.49 g/mol. Its IUPAC name is N-(2H-indazol-3-ylmethyl)-5-[[4-(2-oxopyrrolidin-1-yl)phenyl]methyl]pyridine-3-carboxamide.
Molecular Properties
| Compound Name | N-(2H-indazol-3-ylmethyl)-5-[[4-(2-oxopyrrolidin-1-yl)phenyl]methyl]pyridine-3-carboxamide |
|---|---|
| PubChem CID | 118213031 |
| Molecular Formula | C25H23N5O2 |
| Molecular Weight | 425.49 g/mol |
| Exact Mass | 425.19 |
| IUPAC Name | N-(2H-indazol-3-ylmethyl)-5-[[4-(2-oxopyrrolidin-1-yl)phenyl]methyl]pyridine-3-carboxamide |
| SMILES | O=C(NCc1[nH]nc2ccccc12)c1cncc(Cc2ccc(N3CCCC3=O)cc2)c1 |
| InChI | InChI=1S/C25H23N5O2/c31-24-6-3-11-30(24)20-9-7-17(8-10-20)12-18-13-19(15-26-14-18)25(32)27-16-23-21-4-1-2-5-22(21)28-29-23/h1-2,4-5,7-10,13-15H,3,6,11-12,16H2,(H,27,32)(H,28,29) |
| InChIKey | HSQZGUMGEUJRFC-UHFFFAOYSA-N |
| XLogP | 3.61 |
| TPSA | 90.98 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 425.49 |
| LogP ≤ 5 | 3.61 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118213031 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.